Related Experiment Video
Updated: Jun 18, 2026

05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
[Interactions with antiretroviral drugs]
A Ceschi1, I Curkovic, J Kirchheiner
1Wissenschaftlicher Dienst, Schweizerisches Toxikologisches Informationszentrum, Zürich, Schweiz.
Der Internist
|November 28, 2009
Summary
Drug interactions are common in HIV patients on antiretroviral therapy. Managing these requires adjusting medication doses due to protease inhibitors affecting drug metabolism and transport proteins.
Area of Science:
- Pharmacology
- Drug Metabolism
- HIV Therapeutics
Context:
- Highly active antiretroviral therapy (HAART) for HIV involves multiple drugs.
- Patients often require additional medications for opportunistic infections and comorbidities.
- Protease inhibitors (PIs) are key components of HAART and significantly impact drug metabolism.
Purpose:
- To review drug-drug interactions (DDIs) in HIV-infected patients.
- To highlight the role of cytochrome P450 3A4 (CYP3A4) and other enzymes/transporters in DDIs.
- To discuss management strategies for preventing adverse events due to DDIs.
Summary:
- Protease inhibitors, particularly ritonavir, inhibit CYP3A4, affecting metabolism of many drugs like statins and antibiotics.
- Non-nucleoside reverse transcriptase inhibitors (NNRTIs) like efavirenz can induce CYP3A4 activity over time.
- Interactions also involve glucuronosyltransferases and P-glycoprotein (P-gp), with ritonavir inhibiting P-gp, increasing exposure to chemotherapy agents.
Impact:
- Understanding these interactions is crucial for optimizing HAART efficacy and safety.
- Dose adjustments of co-administered drugs are necessary to prevent toxicity or sub-therapeutic levels.
- This knowledge aids clinicians in managing complex polypharmacy in HIV patients.
More Related Videos
Related Concept Videos
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...
Pharmacokinetics: Drug–Drug Interactions
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...

